pH-Sensitive Lipid Nanoparticle for NK Cell Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lipid nanoparticles, such as those containing YSK12-C4, face challenges in delivering siRNA to NK cells with high efficiency and are associated with toxicity, which is alleviated by reducing the lipid content but results in decreased gene knockdown activity.
Innovation Solution
A lipid nanoparticle with a pH-sensitive cationic lipid having a pKa of 8.0 to 8.5 and a specific hydrocarbon chain structure, combined with sterol and polyalkylene glycol-modified lipids, is used to enhance nucleic acid introduction efficiency and reduce toxicity in NK cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the content of YSK12-C4 in the lipid nanoparticle is increased, then gene knockdown activity is improved, but toxicity increases
Solution Approach 1:
The patent changes the pKa parameter of the pH-sensitive cationic lipid from the conventional range (below 7.4) to a higher range (8.0 to 8.5). This parameter change allows the lipid to maintain cationic properties at physiological pH, improving NK cell uptake and gene knockdown activity while reducing toxicity compared to conventional lipids that require higher concentrations and thus higher toxicity to achieve the same effect.
Solution Approach 2:
The patent uses a composite lipid structure combining a pH-sensitive cationic lipid with specific hydrocarbon chains (containing ester structures at positions 3 or 7) with other lipid components. This composite material approach creates a synergistic effect where the unique lipid structure achieves both high gene delivery efficiency and low toxicity, resolving the contradiction between effectiveness and safety.
2Productivity
If the lipid nanoparticle is designed for high NK cell delivery efficiency, then gene introduction efficiency is improved, but toxicity to NK cells increases
Solution Approach 1:
By changing the pKa parameter to 8.0-8.5 and incorporating ester structures at specific positions (3 or 7) in the hydrocarbon chain, the lipid achieves optimal balance between NK cell membrane interaction (improving uptake efficiency) and biocompatibility (reducing toxicity). The ester groups provide appropriate hydrophobicity and membrane interaction without excessive cytotoxicity.
Solution Approach 2:
The patent introduces ester structures at specific local positions (3rd or 7th carbon) in the hydrocarbon chain rather than uniformly throughout. This local modification creates specific interaction sites with NK cell membranes that enhance uptake efficiency while the rest of the molecule maintains low toxicity characteristics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lipid nanoparticle achieves high gene expression in NK cells with low toxicity, serving as an effective NK cell-specific gene delivery carrier for gene therapy and cancer treatment.
Implementation Method 1
a pH-sensitive cationic lipid which is electrically neutral at physiological pH and turns into cationic property in a weakly acidic pH environment such as endosome
Implementation Method 2
a lipid nanoparticle comprising a pH-sensitive cationic lipid... in which a nucleic acid is encapsulated
Data Source
AI summary
The present invention provides a lipid nanoparticle and the like containing a pH-sensitive cationic lipid represented by formula (1) (in formula (1), R1 and R2 are each independently a straight-chain C10-14 alkyl group, a straight-chain C10-20 alkenyl group having one or two unsaturated bonds, or —CH(R5)(R6)(where R5 and R6 are each independently a straight-chain C5-10 alkyl group); p represents an integer of 3-8; and R3 and R4 are each independently a methyl group or an ethyl group].